Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vector U loop in patients with idiopathic cardiomyopathy.

T Fujimoto1, K Kiyoshige, Y Saito

  • 1Second Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.

Journal of Electrocardiology
|October 1, 1990
PubMed
Summary

The U loop in vectorcardiograms is larger in hypertrophic cardiomyopathy, particularly apical hypertrophy, and shifts anteriorly/rightward in both hypertrophic and dilated cardiomyopathy, correlating with posterior wall thickness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effectiveness of radiotherapy for Merkel cell carcinoma].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7).

Clinical chemistry·1992
Same author

[Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·1992
Same author

[The first cholera case diagnosed early in the clinical laboratory by DNA probe method].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
Same author

Extra-adrenal pheochromocytoma-ganglioneuroma. A case report.

Pathology, research and practice·1992
Same author

[Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·1992

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Vectorcardiography (VCG) provides unique spatial insights into cardiac electrical activity.
  • The U loop in VCG, representing late ventricular repolarization, has not been fully characterized in various cardiomyopathies.
  • Understanding U loop characteristics may offer diagnostic markers for myocardial disease.

Purpose of the Study:

  • To investigate the spatial characteristics of the U loop in patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
  • To correlate U loop findings with echocardiographic parameters, particularly left ventricular wall thickness.
  • To determine if U loop alterations can differentiate between HCM subtypes and DCM.

Main Methods:

  • Recorded U loops from vectorcardiograms in 50 normal subjects, 10 DCM patients, and 83 HCM patients (including obstructive HCM, nonobstructive HCM, and apical hypertrophy subgroups).

Related Experiment Videos

  • Analyzed U loop spatial characteristics qualitatively and quantitatively.
  • Correlated U loop parameters with echocardiographic measurements of left ventricular hypertrophy.
  • Main Results:

    • U loop magnitude was significantly increased in the HCM group (especially apical hypertrophy) compared to controls, but not in the DCM group.
    • The maximum U vector showed significant anterior and rightward displacement in both DCM and HCM groups, most pronounced in apical hypertrophy and nonobstructive HCM.
    • U loop magnitude correlated with posterior left ventricular wall thickness in nonobstructive HCM and apical hypertrophy subgroups.

    Conclusions:

    • The U loop is significantly altered in hypertrophic cardiomyopathy, reflecting hypertrophy of the left ventricular apex and posterior wall.
    • U loop spatial displacement is observed in both hypertrophic and dilated cardiomyopathies.
    • U loop analysis may serve as a valuable tool for assessing myocardial structural changes in cardiomyopathies.